Blincyto 38.5 mcg Solution for infusion

Active Molecule: Blinatumomab 38.5mcgGeneric Formulations →

Branded and Generic MedicinesSuper speciality Medicines

Select Quantity

Pack

Description

Blincyto (blinatumomab) 38.5 mcg is a prescription immunotherapy medication used to treat specific types of CD19-positive B-cell precursor acute lymphoblastic leukemia (ALL).

Product Information

Form

Solution for infusion

Strength

38.5 mcg

Pack Size

One vial of lyophilized powder (38.5 mcg) and one vial of IV Solution Stabilizer.

Storage

Store below 30o C

Manufactured By

Amgen In

Marketed By / TM Owner

Amgen In

Institutional Quality & Supply Assurance

WHO-GMP & GDP Certified – Meeting Global Pharmaceutical Standards for Trusted International Trade

✓ Audited Supply Chain

Authorised Sourcing

Procured through authorised distributors and companies, ensuring reliable quality and supply chain traceability.

Cold-Chain Monitored

Active temperature logging during air cargo export, maintaining Refrigerated (2°C–8°C) and CRT (15°C–25°C) conditions as per international shipping standards.

QA Verified

Pre-dispatch inspection, tamper-evident packing, and documentation verification for every shipment.

Uses

Treat specific types of B-cell precursor Acute Lymphoblastic Leukemia (ALL), B-ALL or those with minimal residual disease (MRD)

Disclaimer

At ExSell Laboratories Pvt. Ltd., we aim to provide information that is accurate and reliable. All content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While every effort is made to maintain accuracy, the information provided may contain errors or omissions, or may not reflect the latest developments. Please consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks, and registered trademarks displayed on this website are the property of their respective owners. ExSell Laboratories Pvt. Ltd. and this website are not affiliated with, endorsed by, or authorized by any such trademark owners, unless expressly stated. References to product names or trademarks are made solely for descriptive and informational purposes, and no commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Nothing herein constitutes promotion, advertising, or an offer for sale of any medicinal product.

All trademarks and brand names on this website are used strictly in accordance with the Trade Marks Act, 1999 — specifically Sections 30 and 30(1) governing fair use — and any related parallel trade is conducted consistent with the trademark exhaustion and fair-use provisions of the Act, as well as India's obligations as a WTO member under the TRIPS Agreement.

"Trademark ownership is duly attributed under the 'Marketing/TM Owner' section in accordance with applicable statutory requirements."

Medical & Supply FAQs

Frequently Asked Questions about Blincyto 38.5 mcg Solution for infusion

Essential information on active composition, WHO-GMP & GDP certification, cold-chain storage, and international export.

What is Blincyto 38.5 mcg Solution for infusion and what active ingredient does it contain?

Blincyto 38.5 mcg Solution for infusion is a certified pharmaceutical product from our Global export catalogue formulated as a Solution for infusion (38.5 mcg). It contains the active pharmaceutical ingredient Blinatumomab 38.5mcg, manufactured by Amgen In.

Who manufactures Blincyto 38.5 mcg Solution for infusion and is it quality certified?

Blincyto 38.5 mcg Solution for infusion is manufactured by Amgen In – WHO-GMP & GDP Certified – Meeting Global Pharmaceutical Standards for Trusted International Trade. ExSell Laboratories delivers authenticated batches sourced through verified, compliant supply channels, backed by complete regulatory documentation.

How should Blincyto 38.5 mcg Solution for infusion be stored to maintain potency?

Blincyto 38.5 mcg Solution for infusion must be stored according to manufacturer instructions: Store below 30o C. ExSell Laboratories maintains active temperature logging during air cargo export, maintaining Refrigerated (2°C–8°C) and CRT (15°C–25°C) conditions as per international shipping standards.

Can Blincyto 38.5 mcg Solution for infusion be ordered in bulk for international export?

Yes, ExSell Laboratories is a licensed global pharmaceutical exporter supplying hospitals, pharmacies, government procurement agencies, and distributors in 45+ countries. Contact our sales team for bulk quotation, MOQ, and international shipping options.

Therapeutic Alternatives